Valuation: Ipsen

Market Cap 1.32TCr 1.51TCr 1.22TCr 1.12TCr 2.12TCr 1,45100Cr 2.15TCr 15TCr 5.7TCr 71TCr 5.66TCr 5.54TCr 2,44500Cr P/E 2026 *
14.5x
P/E 2027 * 14x
Enterprise Value 1.18TCr 1.34TCr 1.08TCr 997.17Cr 1.89TCr 1,29400Cr 1.92TCr 13TCr 5.08TCr 63TCr 5.05TCr 4.94TCr 2,18000Cr EV / Sales 2026 *
2.74x
EV / Sales 2027 * 2.39x
Free-Float
40.65%
Yield 2026 *
0.95%
Yield 2027 * 0.94%
1 day-1.47%
1 week-4.57%
Current month-4.45%
1 month+3.61%
3 months-1.35%
6 months+19.52%
Current year+35.55%
1 week 157.3
Extreme 157.3
169.6
1 month 151.7
Extreme 151.7
174.9
Current year 116
Extreme 116
176.6
1 year 101.9
Extreme 101.9
176.6
3 years 88.05
Extreme 88.05
176.6
5 years 77.28
Extreme 77.28
176.6
10 years 35.52
Extreme 35.52
176.6
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Change 5-day change 1-year change 3-year change Capi.($)
-1.47%-4.57% - - 1.51TCr
+1.34%-3.12%+49.27%+163.66% 1,03100Cr
+1.26%-2.91%+52.66%+58.14% 59TCr
+2.67%+0.70%+32.05%+86.65% 43TCr
-0.41%-1.91%+28.45%+22.71% 33TCr
+0.33%-1.16%+29.16%+44.68% 28TCr
-0.40%-5.99%+20.30%+23.08% 26TCr
+1.67%+5.23%-22.30%-37.15% 22TCr
+1.96%+0.96%+22.77%+61.12% 19TCr
+0.87%-0.80%+21.77%+72.64% 16TCr
Average +0.80%-3.79%+26.02%+55.06% 38.94TCr
Weighted average by Cap. +1.16%-4.31%+34.71%+80.47%

Financials

2026 *2027 *
Net sales 428.71Cr 490.35Cr 395.48Cr 363.55Cr 688.84Cr 47TCr 700.61Cr 4.72TCr 1.85TCr 23TCr 1.84TCr 1.8TCr 79TCr 450.11Cr 514.83Cr 415.23Cr 381.69Cr 723.22Cr 50TCr 735.59Cr 4.96TCr 1.95TCr 24TCr 1.93TCr 1.89TCr 83TCr
Net income 95Cr 108.09Cr 87Cr 80Cr 151.85Cr 10TCr 154.44Cr 1.04TCr 408.37Cr 5.08TCr 405.93Cr 397.03Cr 18TCr 97Cr 111.51Cr 90Cr 83Cr 156.65Cr 11TCr 159.33Cr 1.07TCr 421.29Cr 5.24TCr 418.77Cr 409.59Cr 18TCr
Net Debt -142.6Cr -163.11Cr -131.55Cr -120.93Cr -229.13Cr -16TCr -233.05Cr -1.57TCr -616.22Cr -7.67TCr -612.53Cr -599.11Cr -26TCr -242.57Cr -277.44Cr -223.77Cr -205.7Cr -389.75Cr -27TCr -396.41Cr -2.67TCr -1.05TCr -13TCr -1.04TCr -1.02TCr -45TCr
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
16/26/16 160.90 +0.85% 1
15/26/15 €159.10 +1.14% 2,496
14/26/14 €157.30 -2.48% 29
13/26/13 €161.30 -0.55% 18
10/26/10 €162.20 -3.80% 21,017
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
160.60EUR
Average target price
161.33EUR
Spread / Average Target
+0.46%

Quarterly revenue - Rate of surprise